-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
August 18, 2011 - Moreover, as described below in the section discussing health disparities, medication adherence is
particularly … Burden, Scope, and Prevalence of the Problem
As described in this section, poor adherence is very … The steps that we
will take to accomplish the literature review are described below. … As described above, all
results will be tracked in an EndNote database. … We will also abstract intervention characteristics as described in
KQ 3.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
June 01, 2012 - From Stakeholders
The Evidence-based Practice Center (EPC) followed
AHRQ’s recommended methodology, described … We evaluated the quality of
individual studies using the approach described in AHRQ’s
Methods Guide … We used the Rutter and Gatsonis12
SROC curve as described by Arends et al.,13 and it is
presented in … the Body of Evidence
The strength of evidence for each Key Question was
assessed using the approach described … Predictors of
diagnostic accuracy in
women
Insufficient 11 studies (4 good quality, 5 fair, 2 poor) described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
January 15, 2016 - The studies are
well described, with few exceptions described below. … Again, the latent model is described in paragraphs 3 and 4 of Appendix D. … Methods for dealing with these multiple scales are described in
Appendix D. … , not supported by other
literature) and another outlier described the 50% rate of
sleep disturbance … We attempted to ascertain that the
lesions described were true IH but acknowledge that that determination
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
January 01, 2009 - In the intervention column, the type of surgical procedure is described. … In the comparator column, the comparator is described, and then the extent of use of other medications … Important limitations of the applicability of the evidence should be described within each summary conclusion … Finally, we learned that important limitations of the applicability of the evidence should be described
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
November 01, 2010 - Treatments described in this category are focused on delivering an
exogenous substance, typically a … Methods and findings from individual studies are
described accurately. … friendship training post
treatment and at follow up are described. … The use of the quality components is described in the Methods of
the report. … Results The studies were described and arrayed well in
tabular format.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
July 01, 2009 - The Need for a Large, Distributed Research Network
As described above, AHRQ and others (e.g., the IOM … Summary of Existing Networks
Much can be learned from the activities of the networks described above … To help illustrate network capabilities,
the steps described a range of activities from development … The specifications of the proof-of-principle are described below.
9.1. … The primary and secondary objectives of the proof-of-principle are described below.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
June 22, 2017 - The used
defendable methods and described
things pretty well so as to avoid
ambiguity. … This is described
in the Results. … TEP
Reviewer #1
Methods The methods are clearly described and
complete. … The
search strategies were explicitly
described, and were appropriate for the
key questions. … Otherwise, characteristics of the
studies is clearly described.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
August 06, 2014 - Peer Reviewer #4 Discussion/
Conclusion
Limitation were described adequately. … TEP Reviewer #2 Discussion/
Conclusion
the implications are appropriately stated; limitations
described … Peer reviewer #1 General The target population is well described. … The methods for arriving at our assessments are
described in the methods section of the full report. … The inclusion and exclusion criteria are described fully in
the methods section of the full report.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
June 01, 2025 - A prior white paper
described challenges and practical and methodological considerations encountered … A prior white paper2 drew on experience of the first year of the living review3 and
described practical … Based on the considerations described above, we plan to prospectively expand the scope of
the living … The quarterly surveillance reports in the interim were briefer (7 to 10 pages), and described the
new … in the frequency of updates occur in the future,
these will be documented as protocol changes, as described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
June 12, 2012 - Random sequence
generation method
should produce
comparable groups
Not described in
sufficient … risk of bias Reviewer
Assessment
Performance
bias
Blinding
(participants
and personnel)
Described … Not described in
sufficient detail
Judgment: Blinding
(participants and
personnel)
□ High … □ Low
□ Unclear
Detection bias
Blinding
(outcome
assessment)
Described all measures used, … Not described in
sufficient detail
Judgment: Blinding
(outcome
assessment)
□ High
□ Low
□
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
June 05, 2013 - The matter of “…an aversion to high-carbohydrate
foods…” could also be described as a learned behavior … This procedure is
a modification of the BPD described below in the introduction. … Peer Reviewer 5 Methods I found the methods very confusing, as they were inadequately
described
We … The limitations of
the included studies are well-described and defined. … Chiellini is now described in the results section on small
cohort studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - They
described results for individual domains. … When a meta-analysis was not appropriate we
described the reasons, presented data in tabular form, … studies.
9
Applicability
We assessed applicability across our KQs using the
PICOTS format as described … There was also
concern that the population was not adequately described
to assess applicability, included … There was also concern that the population was not
always adequately described to assess applicability
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - o Were inclusion/exclusion criteria clearly described? … o Were baseline prognostic characteristics clearly described and groups shown to be
comparable? … characteristics proposed by Carey and Boden,30 as follows:
o Clearly defined question
o Well-described … study population
o Well-described intervention
o Use of validated outcome measures
o Appropriate … statistical analyses
o Well-described results
o Discussion and conclusion supported by data
o
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain_research-protocol.pdf
February 16, 2011 - An outcome measure described as validated by an authoritative
professional clinical organization (reference … An outcome measure described as validated by the authors of the index study, with a
linked reference … An outcome measure described as validated by the authors of the index study,
without a linked reference … An outcome measure that is not described as validated by the authors of the index
study and is not a … Core Outcome Measure as described above in 1a
For studies that meet the conditions of the second-round
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-introduction_methods.pdf
July 01, 2012 - personal experience and judgment, and to maintain consistency as
much as possible with the principles described … This value has been reiterated in other recommendations for reviewers.12–14
In 1991, Woolf described … a conceptual model that he termed the “Evidence Model,”15 and in
1994, he described this same model … with the current standard approach to classifying contexts, the PICOTS
typology, which is further described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
November 01, 2009 - Most studies reported patient relevant-clinical outcomes: 151 studies (62 percent)
described overall … The complete search strategy is described in Appendix B. … Mean or Median Ages
Only 7 papers focused on pediatric or adolescent populations, and they described … Overall, 46 studies
described more than 300 people. … Cancer specific
outcomes were also described.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
December 14, 2017 - We described the reduction in ED visits
found in the AIR 2 trial, and judged the
strength of evidence … Study characteristics are well described.
Thank you. … The approach is described
more fully in the EPC Methods
Guidance, available on the AHRQ
Effective … The 2 year follow-up data from 279 patients treated in PAS2
described earlier in these comments and … While bronchial artery embolization has
been described as effective in a number
of case series for
-
effectivehealthcare.ahrq.gov/sites/default/files/selection-of-data-sources-chapter-8.pptx
January 01, 2013 - The observational research designs that often require primary data collection are described below:
Prospective … The observational research designs that require primary data collection are described here.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
March 10, 2010 - for confusion, we believe that it is critical
that this limited focus be consistently and clearly described … We also think that the conclusions that are described in the report should
be very carefully written … Methods from publication described below:
“In this study, following a 6-week double-blind phase in which … Also add LDL-C results to the Table on page
The trial population is better described under CPK results … (Ref 35)
Davidson was penalized because "no intention-to-treat analysis was
described".
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
October 05, 2015 - The latter include, for example, the medication protocols described in the emergency
department-focused … Other strategies targeted to decrease aggression for those who are actively
aggressive, as described … described!in!project!BETA!
•! Any!intervention,!or!combination!of!
interventions,!different!from! … described!above!for!KQs!1a!and!2a!
All!KQs!
•! A!study!with!no!comparison!group!
•! For! … described!above!for!KQs!
1b/1c!and!2b/2c!
•! Seclusion!or!restraint!(for!1b!and!2b!only):!
!